참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | HCID 178419772 | HCID 178419772 | — |
| 반응물 | HCID 178506202 | HCID 178506202 | — |
| 촉매 | HCID 178418397 | HCID 178418397 | — |
| 생성물 | HCID 178506201 | HCID 178506201 | 7.1% |
반응 단계
7-Chloro-4-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-1H-imidazo[4,5-d]pyridazine (149 mg, 0.389 mmol), benzyl zinc bromide (9.34 mL, 0.5M in THF, 4.67 mmol), and tetrakis (triphenylphosphine) palladium0 (23 mg, 0.020). The reaction mixture is heated to 80° C. for 32 h. Add H2O and extract product with EtOAc. Wash combined organics with brine and concentrate in vacuo. The residue is purified by flash chromatography on silica gel (60-100% EtOAc/Heptane flushed with 10% MeOH/EtOAc) to afford the title compound (12.1 mg, 7%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08536168B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_09 |
|---|
| ORD ID | ord-a82b8d3137e643f49069a1098564f096 |
|---|
| 출처 메모 | uspto-grants-2013_09 |
|---|